TechBio Startup Generare Raises 20 Million Euros to Unlock Novel Drug Discovery Data
Generare, a techbio company focused on generating novel molecular data for drug discovery, has raised 20 million euros in a Series A funding round co-led by Alven and Daphni, with participation from existing investors including Galion.exe, Teampact Ventures and VIVES Partners.
Novel Drug Discovery Data | 04/04/2026 | By Darshana | 122
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy